Issue Date: June 27, 2016
Cipla licenses HIV drugs to Russia
India’s Cipla has signed a memorandum of understanding with the Russian firm National Immunobiological Co. (Nacimbio) concerning the use of Cipla technology for Russian manufacturing of antiviral drugs to treat HIV and hepatitis C. Russia currently does not produce the treatments. Investment on the project will approach $45 million, Nacimbio says. Cipla is one of the world’s largest producers of HIV drugs.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society